Precision medicine is based on the identification of biomarkers of tumor development and progression.Liquid biopsy is at the forefront of the ability to gather diagnostic and prognostic information on tumors,as it can...Precision medicine is based on the identification of biomarkers of tumor development and progression.Liquid biopsy is at the forefront of the ability to gather diagnostic and prognostic information on tumors,as it can be noninvasively performed prior or during treatment.Liquid biopsy mostly utilizes circulating tumor cells,or free DNA,but also exosomes.The latter are nanovesicles secreted by most cell types,found in any body fluid that deliver proteins,nucleic acids and lipids to nearby and distant cells with a unique homing ability.Exosomes function in signalling between the tumor microenvironment and the rest of the body,promoting metastasis,immune remodelling and drug resistance.Exosomes are emerging as a key tool in precision medicine for cancer liquid biopsy,as they efficiently preserve their biomarker cargo.Moreover,exosomes strongly resemble the parental cell,which can help in assessing the oxidative and metabolic state of the donor cell.In this respect,exosomes represent one of the most promising new tools to fight cancer.This review will discuss the clinical applications of profiling exosomal proteins and lipids by high-throughput proteomics and metabolomics,and nucleic acids by next generation sequencing,as well as how this may allow cancer diagnosis,therapy response monitoring and recurrence detection.展开更多
基金This study was supported by the Italian Ministry of Health-Cinque per mille and Ricerca Corrente to Istituto Giannina Gaslini and Fondazione Malattie Renali del Bambino OLNUS.
文摘Precision medicine is based on the identification of biomarkers of tumor development and progression.Liquid biopsy is at the forefront of the ability to gather diagnostic and prognostic information on tumors,as it can be noninvasively performed prior or during treatment.Liquid biopsy mostly utilizes circulating tumor cells,or free DNA,but also exosomes.The latter are nanovesicles secreted by most cell types,found in any body fluid that deliver proteins,nucleic acids and lipids to nearby and distant cells with a unique homing ability.Exosomes function in signalling between the tumor microenvironment and the rest of the body,promoting metastasis,immune remodelling and drug resistance.Exosomes are emerging as a key tool in precision medicine for cancer liquid biopsy,as they efficiently preserve their biomarker cargo.Moreover,exosomes strongly resemble the parental cell,which can help in assessing the oxidative and metabolic state of the donor cell.In this respect,exosomes represent one of the most promising new tools to fight cancer.This review will discuss the clinical applications of profiling exosomal proteins and lipids by high-throughput proteomics and metabolomics,and nucleic acids by next generation sequencing,as well as how this may allow cancer diagnosis,therapy response monitoring and recurrence detection.
